Age, genetics, the amount of weight lost, and the pace of weight loss all influence how much the skin rebounds
Key Features & Benefits: Dual-Action Mechanism As a GIP and GLP-1 receptor agonist, Zepbound works by reducing appetite, slowing gastric emptying, and enhancing feelings of fullness to support meaningful calorie reduction and fat loss
Only one of the trials included in the systematic review used the next-generation GLP-1 agonist semaglutide to treat obesity in adolescents aged 1218 years, and none used the combined GLP-1 and glucose-dependent insulinotropic peptide agonist, tirzepatide
Weight Loss With Tirzepatide More than 1 billion people worldwide live with obesity
Clinical studies, including SURMOUNT-4, have shown that patients who discontinue GLP-1 receptor agonists typically regain a significant portion of lost weight within the first year